FDA Acceptance of Supplement for ZUBSOLV by Edenbridge Pharmaceuticals
The FDA has accepted a supplemental application (NDA204242) for ZUBSOLV, containing buprenorphine hydrochloride and naloxone hydrochloride, submitted by Edenbridge Pharmaceuticals.